Solstice

Solstice is an AI-native marketing agency accelerating pharma commercialization. From its funding announcement.

$21M Series ARaised 5 months agoNYC, USABiotech & PharmaUSA

In their own words

What Solstice says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "AI-native marketing agency accelerating pharma commercialization". Source

Commercial growth

Public signal Read from the company's own description of what the funding supports.

Why now

Where Solstice is today

Solstice announced a Series A round of $21M on 28 May 2026.

Latest round
Series A
Amount
$21M
Announced
28 May 2026
Headquarters
NYC, USA
Sector
Biotech & Pharma
Investors
Not stated
Also participating
Not stated
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

45
Steady growth
0 funding signals in the last 90 days
Funding recency
18/40
announced within the last 6 months
Round scale
12/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 28 May 2026
    $21M Series A
    Investors not stated in the announcement.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Commercial team build-out
  • Revenue leadership appointments
  • Repeatable go-to-market build
  • First senior commercial hires

Opportunities this could create

  • Scientific hiring
  • Licensing and BD partnerships
  • Revenue leadership
  • Channel partners
  • Sales hiring

Based on the Biotech & Pharma sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Early momentum2 connected signals
  • 28 May 2026$21M Series A announced
  • 28 May 2026Stated priority: commercial growth

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Solstice is open to

Not yet specified

Solstice has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Solstice

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Solstice?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: your website, the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector